Arcutis Biotherapeutics (ARQT) earnings, Aug 5, 2026: EPS +185%, stock −2.5%
In brief
Arcutis Biotherapeutics reported on Aug 5, 2026. Earnings per share changed +185% year over year, 99.7% above the estimate; revenue +59%. The stock opened with a +7.8% gap and closed the day −2.5% (Aug 6, 2026). The stock is now 22.4% below its 52-week high, +10.7% over 12 months. Next report: Mar 2, 2027.
EPS vs estimate+99.7%
EPS, YoY+185%
Revenue, YoY+59%
Gap · day+7.8% · −2.5%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 5, 2026 | +7.8% | −2.5% |
Next-quarter estimates, ratings and the ARQT chart are in the terminal.
Open the terminalFAQ
When is Arcutis Biotherapeutics's next earnings report?
Mar 2, 2027. The date comes from daily data and is corrected if the company moves it.
How did Arcutis Biotherapeutics stock react to the report?
Opening gap +7.8%, day's result −2.5%.
Did Arcutis Biotherapeutics's earnings grow?
Earnings per share rose 185% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.